Michelson-Morley: The Great Failure

On July 12, 1887 Albert A. Michelson and Edward W Morley made the final measurements in an experiment that inadvertently changed forever the way we view the workings of the universe. The pair hoped to prove the existence of the ether—the invisible fluid thought to permeate the universe and to serve as the medium through which light waves travel. Michelson modified the interfërometer—a device that splits a single beam of light into two and then recombines the two parts into one s

Written byDorothy Michelson Livingston
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Two changes improved the apparatus over the one used at Potsdam [in 1886]. Morley suggested floating the heavy sand stone slab bearing the optical parts on mer cury. The stone, about 5 feet square, was mounted on a doughnut-shaped wooden block, which floated in a cast-iron trough containing the mercury. This method was economical and efficient, for the mercury-bearing removed practically all stresses and allowed the interferometer to glide smoothly around all points of the compass. Vibrations from outside disturbances, so troublesome in Berlin and even in Potsdam, were virtually eliminated.

With the new "interferential refractometer" Michelson and Morley were able to determine effects of the second order with an accuracy hitherto unobtainable. The second improvement lay in placing the mirrors so that the light was reflected over a path about 10 times longer than that of the earlier experiment.

While the stone, floating on its channel of mercury, turned ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies